| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
David Leslie Adams last filed a Form 4 in May 2023, as Director at CDLX. David Leslie Adams's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 40,514 shares of CDLX. The CDLX filings lean toward selling, a net 67,500 shares.
David Leslie Adams has 16 Form 4 filings on record from February 2018 to May 2023, all as Director at Cardlytics (CDLX), 2018–2023.
The 36 reported transactions were 14 open-market sales, 13 option exercises, 8 option or other derivative awards and 1 conversion.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $5.4M.
The largest open-market sale was 23,750 shares of CDLX at an average $111.44 on November 13, 2020, about $2.6M.
Shares as reported in the last Form 4 for each company; the most recent is from May 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2020 | CDLX Cardlytics, Inc. | Director | Sale+OE | 23,750 | $111.44 | $2,646,764.94 | -43.9% | |
| Jun 1, 2020 | CDLX Cardlytics, Inc. | Director | Sale+OE | 10,000 | $68.36 | $683,600.66 | -29.4% | |
| May 28, 2020 | CDLX Cardlytics, Inc. | Director | Sale+OE | 10,000 | $64.70 | $646,950.00 | -29.4% | |
| Dec 2, 2019 | CDLX Cardlytics, Inc. | Director | Sale+OE | 23,750 | $58.75 | $1,395,352.50 | -56.9% |